15.04.2012 22:20 Uhr, Quelle: Wallstreet online

Encouraging Phase III Study Results Show PET Imaging with Florbetaben Reliably Detects Beta-Amyloid in the Brain

MUMBAI, India, April 15, 2012 /PRNewswire/ Piramal Imaging SA ("Piramal"), a newly formed subsidiary of Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302], announced positive first results from a Phase III study that showed that PET …

Weiterlesen bei Wallstreet online